NCT07788664
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07788664
Title Local and Systemic Immune Modulation by Rilvegostomig (AZD2936) in the Treatment of Advanced Gastric Cancer (RILVE Project) (RILVE)
Acronym RILVE
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vall d'Hebron Institute of Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.